Protara Therapeutics, Inc. Operating Income
Protara Therapeutics, Inc. (TARA) reported Operating Income of -$23.32 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-11
- Protara Therapeutics, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$23.32M.
- Protara Therapeutics, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$19.63M.
- Protara Therapeutics, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$19.08M.
- Protara Therapeutics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$14.76M.
- Protara Therapeutics, Inc. operating income (loss) for fiscal 2025 was -$64.55M.
- Protara Therapeutics, Inc. operating income (loss) for fiscal 2024 was -$49.15M.
- Protara Therapeutics, Inc. operating income (loss) for fiscal 2023 was -$43.61M.
- Protara Therapeutics, Inc. operating income (loss) for fiscal 2022 was -$67.06M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$23.32M 10-Q · filed 2026-08-11 | -$42.95M 10-Q · filed 2026-08-11 | -$62.03M derived: sum of 3 quarters · filed 2026-08-11 | -$76.79M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | -$19.63M 10-Q · filed 2026-05-13 | -$38.71M derived: sum of 2 quarters · filed 2026-05-13 | -$53.47M derived: sum of 3 quarters · filed 2026-05-13 | -$70.05M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | -$19.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$33.84M derived: sum of 2 quarters · filed 2026-03-10 | -$50.42M derived: sum of 3 quarters · filed 2026-08-11 | -$64.55M 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | -$14.76M 10-Q · filed 2025-11-10 | -$31.35M derived: sum of 2 quarters · filed 2026-08-11 | -$45.47M 10-Q · filed 2025-11-10 | -$59.78M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | -$16.59M 10-Q · filed 2026-08-11 | -$30.71M 10-Q · filed 2026-08-11 | -$45.02M derived: sum of 3 quarters · filed 2026-08-11 | -$57.35M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | -$14.12M 10-Q · filed 2026-05-13 | -$28.44M derived: sum of 2 quarters · filed 2026-05-13 | -$40.77M derived: sum of 3 quarters · filed 2026-05-13 | -$51.43M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$14.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$26.64M derived: sum of 2 quarters · filed 2026-03-10 | -$37.30M derived: sum of 3 quarters · filed 2026-03-10 | -$49.15M 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | -$12.33M 10-Q · filed 2025-11-10 | -$22.99M derived: sum of 2 quarters · filed 2025-11-10 | -$34.84M 10-Q · filed 2025-11-10 | -$45.88M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | -$10.66M 10-Q · filed 2025-08-11 | -$22.51M 10-Q · filed 2025-08-11 | -$33.55M derived: sum of 3 quarters · filed 2025-08-11 | -$44.25M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | -$11.85M 10-Q · filed 2025-05-08 | -$22.89M derived: sum of 2 quarters · filed 2025-05-08 | -$33.59M derived: sum of 3 quarters · filed 2025-05-08 | -$45.73M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | -$11.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$21.74M derived: sum of 2 quarters · filed 2025-03-05 | -$33.88M derived: sum of 3 quarters · filed 2025-03-05 | -$43.61M 10-K · filed 2025-03-05 | ||||
| 2023-09-30 | -$10.70M 10-Q · filed 2024-11-12 | -$22.84M derived: sum of 2 quarters · filed 2024-11-12 | -$32.57M 10-Q · filed 2024-11-12 | -$72.08M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$12.14M 10-Q · filed 2024-08-06 | -$21.87M 10-Q · filed 2024-08-06 | -$61.38M derived: sum of 3 quarters · filed 2024-08-06 | -$69.36M derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | -$9.73M 10-Q · filed 2024-05-02 | -$49.24M derived: sum of 2 quarters · filed 2024-05-02 | -$57.22M derived: sum of 3 quarters · filed 2024-05-02 | -$65.92M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | -$39.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$47.48M derived: sum of 2 quarters · filed 2024-03-13 | -$56.19M derived: sum of 3 quarters · filed 2024-03-13 | -$67.06M 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | -$7.97M 10-Q · filed 2023-11-03 | -$16.68M derived: sum of 2 quarters · filed 2023-11-03 | -$27.55M 10-Q · filed 2023-11-03 | -$37.84M derived: sum of 4 quarters · filed 2023-11-03 | ||||
| 2022-06-30 | -$8.71M 10-Q · filed 2023-08-03 | -$19.58M 10-Q · filed 2023-08-03 | -$29.87M derived: sum of 3 quarters · filed 2023-08-03 | -$40.70M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | -$10.87M 10-Q · filed 2023-05-04 | -$21.16M derived: sum of 2 quarters · filed 2023-05-04 | -$31.99M derived: sum of 3 quarters · filed 2023-05-04 | -$44.78M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | -$10.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$21.12M derived: sum of 2 quarters · filed 2023-03-08 | -$33.91M derived: sum of 3 quarters · filed 2023-03-08 | -$47.49M 10-K · filed 2023-03-08 | ||||
| 2021-09-30 | -$10.83M 10-Q · filed 2022-11-03 | -$23.62M derived: sum of 2 quarters · filed 2022-11-03 | -$37.20M 10-Q · filed 2022-11-03 | -$46.16M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | -$12.79M 10-Q · filed 2022-08-09 | -$26.37M 10-Q · filed 2022-08-09 | -$35.33M derived: sum of 3 quarters · filed 2022-08-09 | -$43.39M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$13.58M 10-Q · filed 2022-05-05 | -$22.54M derived: sum of 2 quarters · filed 2022-05-05 | -$30.60M derived: sum of 3 quarters · filed 2022-05-05 | -$37.87M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | -$8.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | -$17.02M derived: sum of 2 quarters · filed 2022-03-09 | -$24.29M derived: sum of 3 quarters · filed 2022-03-09 | -$34.44M 10-K · filed 2022-03-09 | ||||
| 2020-09-30 | -$8.06M 10-Q · filed 2021-11-04 | -$8.06M 10-Q · filed 2020-11-12 | -$15.33M derived: sum of 2 quarters · filed 2021-11-04 | -$25.49M 10-Q · filed 2021-11-04 | -$25.49M 10-Q · filed 2020-11-12 | -$28.01M derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | -$7.27M 10-Q · filed 2021-08-05 | -$7.27M 10-Q · filed 2020-07-31 | -$17.43M 10-Q · filed 2021-08-05 | -$17.43M 10-Q · filed 2020-07-31 | -$19.95M derived: sum of 3 quarters · filed 2021-08-05 | -$22.30M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | -$10.16M 10-Q · filed 2021-05-06 | -$10.16M 10-Q · filed 2020-05-13 | -$12.68M derived: sum of 2 quarters · filed 2021-05-06 | -$15.03M derived: sum of 3 quarters · filed 2021-05-06 | -$16.46M derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | -$2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$4.87M derived: sum of 2 quarters · filed 2021-03-11 | -$6.30M derived: sum of 3 quarters · filed 2021-03-11 | -$7.83M 10-K · filed 2021-03-11 | -$15.25M 10-K · filed 2020-03-20 | |||
| 2019-09-30 | -$2.35M 10-Q · filed 2020-11-12 | -$1.59M 10-Q · filed 2019-10-31 | -$3.78M derived: sum of 2 quarters · filed 2020-11-12 | -$5.31M 10-Q · filed 2020-11-12 | -$13.61M 10-Q · filed 2019-10-31 | -$10.70M derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | -$1.43M 10-Q · filed 2020-07-31 | -$5.39M 10-Q · filed 2019-08-07 | -$2.96M 10-Q · filed 2020-07-31 | -$12.02M 10-Q · filed 2019-08-07 | -$8.34M derived: sum of 3 quarters · filed 2020-07-31 | -$12.96M derived: sum of 4 quarters · filed 2020-07-31 | ||
| 2019-03-31 | -$1.53M 10-Q · filed 2020-05-13 | -$6.64M 10-Q · filed 2019-05-08 | -$6.91M derived: sum of 2 quarters · filed 2020-05-13 | -$11.54M derived: sum of 3 quarters · filed 2020-05-13 | -$16.54M derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | -$5.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | -$10.01M derived: sum of 2 quarters · filed 2020-03-20 | -$15.01M derived: sum of 3 quarters · filed 2020-03-20 | -$21.37M 10-K · filed 2020-03-20 | ||||
| 2018-09-30 | -$4.62M 10-Q · filed 2019-10-31 | -$9.62M derived: sum of 2 quarters · filed 2019-10-31 | -$15.99M 10-Q · filed 2019-10-31 | -$21.58M derived: sum of 4 quarters · filed 2019-10-31 | ||||
| 2018-06-30 | -$5.00M 10-Q · filed 2019-08-07 | -$11.37M 10-Q · filed 2019-08-07 | -$16.95M derived: sum of 3 quarters · filed 2019-08-07 | -$29.26M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | -$6.37M 10-Q · filed 2019-05-08 | -$11.96M derived: sum of 2 quarters · filed 2019-05-08 | -$24.26M derived: sum of 3 quarters · filed 2019-05-08 | -$30.25M derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | -$5.59M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$17.90M derived: sum of 2 quarters · filed 2019-03-13 | -$23.88M derived: sum of 3 quarters · filed 2019-03-13 | -$30.36M 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | -$12.31M 10-Q · filed 2018-11-07 | -$18.29M derived: sum of 2 quarters · filed 2018-11-07 | -$24.77M 10-Q · filed 2018-11-07 | -$31.64M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-06-30 | -$5.99M 10-Q · filed 2018-08-07 | -$12.47M 10-Q · filed 2018-08-07 | -$19.33M derived: sum of 3 quarters · filed 2019-03-13 | -$26.50M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-03-31 | -$6.48M 10-Q · filed 2018-05-09 | -$13.35M derived: sum of 2 quarters · filed 2019-03-13 | -$20.51M derived: sum of 3 quarters · filed 2019-03-13 | -$28.37M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2016-12-31 | -$6.87M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$14.03M derived: sum of 2 quarters · filed 2019-03-13 | -$21.89M derived: sum of 3 quarters · filed 2019-03-13 | -$28.70M 10-K · filed 2019-03-13 | ||||
| 2016-09-30 | -$7.17M 10-Q · filed 2017-11-07 | -$15.02M derived: sum of 2 quarters · filed 2017-11-07 | -$21.84M 10-Q · filed 2017-11-07 | -$28.03M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2016-06-30 | -$7.85M 10-Q · filed 2017-08-07 | -$14.67M 10-Q · filed 2017-08-07 | -$20.86M derived: sum of 3 quarters · filed 2018-03-14 | -$25.94M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2016-03-31 | -$6.82M 10-Q · filed 2017-05-10 | -$13.01M derived: sum of 2 quarters · filed 2018-03-14 | -$18.09M derived: sum of 3 quarters · filed 2018-03-14 | -$23.07M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2015-12-31 | -$6.19M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$11.27M derived: sum of 2 quarters · filed 2018-03-14 | -$16.25M derived: sum of 3 quarters · filed 2018-03-14 | -$20.87M 10-K · filed 2018-03-14 | ||||
| 2015-09-30 | -$5.08M 10-Q · filed 2016-11-07 | -$10.06M derived: sum of 2 quarters · filed 2016-11-07 | -$14.68M 10-Q · filed 2016-11-07 | -$17.96M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | -$4.98M 10-Q · filed 2016-08-08 | -$9.60M 10-Q · filed 2016-08-08 | -$12.87M derived: sum of 3 quarters · filed 2017-03-16 | -$12.74M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | -$4.62M 10-Q · filed 2016-05-09 | -$7.89M derived: sum of 2 quarters · filed 2017-03-16 | -$7.76M derived: sum of 3 quarters · filed 2017-03-16 | -$10.27M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | -$3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$3.14M derived: sum of 2 quarters · filed 2017-03-16 | -$5.65M derived: sum of 3 quarters · filed 2017-03-16 | -$7.58M 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | $134.00K 10-Q · filed 2015-11-12 | -$2.37M derived: sum of 2 quarters · filed 2015-11-12 | -$4.31M 10-Q · filed 2015-11-12 | -$6.09M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-06-30 | -$2.51M 10-Q · filed 2015-08-13 | -$4.44M 10-Q · filed 2015-08-13 | -$6.23M derived: sum of 3 quarters · filed 2016-03-14 | -$8.14M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-03-31 | -$1.93M 10-Q · filed 2015-05-13 | -$3.72M derived: sum of 2 quarters · filed 2016-03-14 | -$5.63M derived: sum of 3 quarters · filed 2016-03-14 | |||||
| 2013-12-31 | -$1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$3.70M derived: sum of 2 quarters · filed 2016-03-14 | -$7.12M 10-K · filed 2016-03-14 | |||||
| 2013-09-30 | -$1.91M 10-Q · filed 2014-11-25 | -$5.33M 10-Q · filed 2014-11-25 | ||||||
| 2012-12-31 | -$8.00M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |